RECENT ARTICLES
Serum Antibody Profile of a Patient With Coronavirus Disease 2019 Reinfection
AdvertisementNavbar Search FilterMobile Microsite Search TermNavbar Search FilterMicrosite Search TermArticle NavigationArticle NavigationArticle NavigationArticle NavigationClinical Infectious Diseases, Volume 72, Issue 10, 15 May 2021, Pages e659–e662,Received:Editorial decision:Accepted:Published:Corrected and typeset:Navbar Search FilterMobile Microsite Search TermNavbar Search FilterMicrosite Search TermWe recently reported a patient with coronavirus disease 2019 reinfection. Here, we show that serum neutralizing antibodies could be detected during the first episode but not at the...…AdvertisementNavbar Search FilterMobile Microsite Search TermNavbar Search FilterMicrosite Search TermArticle NavigationArticle NavigationArticle NavigationArticle NavigationClinical Infectious Diseases, Volume 72, Issue 10, 15 May 2021, Pages e659–e662,Received:Editorial decision:Accepted:Published:Corrected and typeset:Navbar Search FilterMobile Microsite Search TermNavbar Search FilterMicrosite Search TermWe recently reported a patient with coronavirus disease 2019 reinfection. Here, we show that serum neutralizing antibodies could be detected during the first episode but not at the...WW…
Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing
AdvertisementNavbar Search FilterMobile Microsite Search TermNavbar Search FilterMicrosite Search TermArticle NavigationArticle NavigationArticle NavigationArticle NavigationClinical Infectious Diseases, Volume 73, Issue 9, 1 November 2021, Pages e2946–e2951,Received:Editorial decision:Accepted:Published:Corrected and typeset:Navbar Search FilterMobile Microsite Search TermNavbar Search FilterMicrosite Search TermBackgroundWaning immunity occurs in patients who have recovered from Coronavirus Disease 2019 (COVID-19). However, it remains unclear whether true re-infection occurs.MethodsWhole...…AdvertisementNavbar Search FilterMobile Microsite Search TermNavbar Search FilterMicrosite Search TermArticle NavigationArticle NavigationArticle NavigationArticle NavigationClinical Infectious Diseases, Volume 73, Issue 9, 1 November 2021, Pages e2946–e2951,Received:Editorial decision:Accepted:Published:Corrected and typeset:Navbar Search FilterMobile Microsite Search TermNavbar Search FilterMicrosite Search TermBackgroundWaning immunity occurs in patients who have recovered from Coronavirus Disease 2019 (COVID-19). However, it remains unclear whether true re-infection occurs.MethodsWhole...WW…
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
AdvertisementNavbar Search FilterMobile Microsite Search TermNavbar Search FilterMicrosite Search TermArticle NavigationArticle NavigationArticle NavigationArticle NavigationClinical Infectious Diseases, Volume 71, Issue 15, 1 August 2020, Pages 732–739,Received:Editorial decision:Published:Accepted:Corrected and typeset:Navbar Search FilterMobile Microsite Search TermNavbar Search FilterMicrosite Search TermBackgroundThe severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first broke out in 2019 and subsequently spread worldwide. Chloroquine has been sporadically used in treating...…AdvertisementNavbar Search FilterMobile Microsite Search TermNavbar Search FilterMicrosite Search TermArticle NavigationArticle NavigationArticle NavigationArticle NavigationClinical Infectious Diseases, Volume 71, Issue 15, 1 August 2020, Pages 732–739,Received:Editorial decision:Published:Accepted:Corrected and typeset:Navbar Search FilterMobile Microsite Search TermNavbar Search FilterMicrosite Search TermBackgroundThe severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) first broke out in 2019 and subsequently spread worldwide. Chloroquine has been sporadically used in treating...WW…
- Total 3 items
- 1
oup.com